5-[[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy]pyridin-2-amine;(9S)-N-[5-[[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy]-2-pyridinyl]-3-methyl-5-[(3S)-4,4,4-trifluoro-3-methylbutanoyl]-1,6,8-triazatricyclo[7.2.1.02,7]dodeca-2(7),3,5-triene-8-carboxamide;(3S)-4,4,4-trifluoro-3-methyl-1-[(9S)-3-methyl-1,6,8-triazatricyclo[7.2.1.02,7]dodeca-2(7),3,5-trien-5-yl]butan-1-one
C53H66F6N10O9 — CID 158115217
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy]pyridin-2-amine;(9S)-N-[5-[[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy]-2-pyridinyl]-3-methyl-5-[(3S)-4,4,4-trifluoro-3-methylbutanoyl]-1,6,8-triazatricyclo[7.2.1.02,7]dodeca-2(7),3,5-triene-8-carboxamide;(3S)-4,4,4-trifluoro-3-methyl-1-[(9S)-3-methyl-1,6,8-triazatricyclo[7.2.1.02,7]dodeca-2(7),3,5-trien-5-yl]butan-1-one
5-[[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy]pyridin-2-amine;(9S)-N-[5-[[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy]-2-pyridinyl]-3-methyl-5-[(3S)-4,4,4-trifluoro-3-methylbutanoyl]-1,6,8-triazatricyclo[7.2.1.02,7]dodeca-2(7),3,5-triene-8-carboxamide;(3S)-4,4,4-trifluoro-3-methyl-1-[(9S)-3-methyl-1,6,8-triazatricyclo[7.2.1.02,7]dodeca-2(7),3,5-trien-5-yl]butan-1-one (PubChem CID 158115217) has the molecular formula C53H66F6N10O9 and a molecular weight of 1101.16 g/mol. Its IUPAC name is 5-[[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy]pyridin-2-amine;(9S)-N-[5-[[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy]-2-pyridinyl]-3-methyl-5-[(3S)-4,4,4-trifluoro-3-methylbutanoyl]-1,6,8-triazatricyclo[7.2.1.02,7]dodeca-2(7),3,5-triene-8-carboxamide;(3S)-4,4,4-trifluoro-3-methyl-1-[(9S)-3-methyl-1,6,8-triazatricyclo[7.2.1.02,7]dodeca-2(7),3,5-trien-5-yl]butan-1-one.
Molecular Properties
| Compound Name | 5-[[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy]pyridin-2-amine;(9S)-N-[5-[[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy]-2-pyridinyl]-3-methyl-5-[(3S)-4,4,4-trifluoro-3-methylbutanoyl]-1,6,8-triazatricyclo[7.2.1.02,7]dodeca-2(7),3,5-triene-8-carboxamide;(3S)-4,4,4-trifluoro-3-methyl-1-[(9S)-3-methyl-1,6,8-triazatricyclo[7.2.1.02,7]dodeca-2(7),3,5-trien-5-yl]butan-1-one |
|---|---|
| PubChem CID | 158115217 |
| Molecular Formula | C53H66F6N10O9 |
| Molecular Weight | 1101.16 g/mol |
| Exact Mass | 1100.49 |
| IUPAC Name | 5-[[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy]pyridin-2-amine;(9S)-N-[5-[[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy]-2-pyridinyl]-3-methyl-5-[(3S)-4,4,4-trifluoro-3-methylbutanoyl]-1,6,8-triazatricyclo[7.2.1.02,7]dodeca-2(7),3,5-triene-8-carboxamide;(3S)-4,4,4-trifluoro-3-methyl-1-[(9S)-3-methyl-1,6,8-triazatricyclo[7.2.1.02,7]dodeca-2(7),3,5-trien-5-yl]butan-1-one |
| SMILES | CC1(C)OC[C@@H](COc2ccc(N)nc2)O1.Cc1cc(C(=O)C[C@H](C)C(F)(F)F)nc2c1N1CC[C@@H](C1)N2.Cc1cc(C(=O)C[C@H](C)C(F)(F)F)nc2c1N1CC[C@@H](C1)N2C(=O)Nc1ccc(OC[C@@H]2COC(C)(C)O2)cn1 |
| InChI | InChI=1S/C27H32F3N5O5.C15H18F3N3O.C11H16N2O3/c1-15-9-20(21(36)10-16(2)27(28,29)30)32-24-23(15)34-8-7-17(12-34)35(24)25(37)33-22-6-5-18(11-31-22)38-13-19-14-39-26(3,4)40-19;1-8-5-11(12(22)6-9(2)15(16,17)18)20-14-13(8)21-4-3-10(7-21)19-14;1-11(2)15-7-9(16-11)6-14-8-3-4-10(12)13-5-8/h5-6,9,11,16-17,19H,7-8,10,12-14H2,1-4H3,(H,31,33,37);5,9-10H,3-4,6-7H2,1-2H3,(H,19,20);3-5,9H,6-7H2,1-2H3,(H2,12,13)/t16-,17-,19+;9-,10-;9-/m001/s1 |
| InChIKey | FQXMKOIORDADDL-QKWFZSALSA-N |
| XLogP | 9.08 |
| TPSA | 217.95 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 17 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 78 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1101.16 |
| LogP ≤ 5 | 9.08 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 17 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158115217 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.